TRAIL plays an imperative role in host immunosurveillance in opposition to tumor progression, as it triggers apoptosis of tumor cells but not normal cells, and therefore has great therapeutic potential for cancer treatment. This evidence concerns the gene TNFSF10 and neoplasm.